Prot # SYN120-CL03: SYN120 a Dual 5-HT6/5-HT2A Antagonist Proof of Concept Study to Evaluate its Safety, Tolerability and Efficacy in Parkinson’s Disease Dementia (SYNAPSE)

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/15 → 1/1/18

Funding

  • Massachusetts General Hospital (SYN120-CL03)
  • Biotie Therapies, Inc. (SYN120-CL03)